Keyphrases
Adult Patients
5%
Adverse Events
13%
Alcoholic
7%
Alcoholic Cirrhosis
8%
Alcoholic Liver Disease
8%
All-cause Mortality
18%
Anesthesia
5%
Antidepressants
6%
Assessment Development
7%
Attention Deficit Hyperactivity Disorder
7%
Beneficial Effects
11%
Blood Pressure
6%
Body Mass Index
9%
Calcitonin Gene-related Peptide
20%
Calcitonin Receptor
7%
Cancer Patients
10%
Cardiac Arrest
9%
Cardiovascular Disease
7%
Cardiovascular Risk
6%
Cerebral Arteries
12%
Cerebral Blood Flow
5%
Certainty of Evidence
7%
Chemotherapy
11%
Chronic Hepatitis C
9%
Clinical Analysis
58%
Clinical Practice Guidelines
7%
Clinical Trials
15%
Clinically Significant
6%
Cochrane
15%
Cochrane Review
6%
Confidence Interval
56%
Copenhagen
10%
COVID-19
6%
Critically Ill Patients
8%
Denmark
18%
Embase
10%
Endothelin B Receptor
6%
Endothelin-1 (ET-1)
11%
Europe
6%
Evaluation Assessment
7%
Exercise Intervention
8%
Grading of Recommendations
7%
Harmful Effects
7%
Hazard Ratio
9%
Health-related Quality of Life
12%
Healthcare Professionals
7%
Hepatobiliary
6%
High Risk
12%
Hypothermia
5%
In Cancer
8%
Intensive Care Unit
12%
Intensive Care Unit Patients
6%
Interferon-α (IFN-α)
8%
Intervention Effect
9%
Intervention Group
9%
Liver Disease
5%
Low Risk
9%
Major Depressive Disorder
8%
MEDLINE
8%
Meta-analysis
70%
Migraine
8%
Myocardial Infarction
6%
Neurological Outcome
6%
Obesity
5%
Odds Ratio
8%
Older Adults
5%
Organ Culture
7%
Out-of-hospital Cardiac Arrest
11%
Paracetamol
5%
Physical Activity
11%
Placebo
39%
Primary Biliary Cirrhosis
6%
Quality of Life
16%
Random Error
8%
Randomized Clinical Trial
100%
Randomized Controlled Trial
27%
Randomized Placebo-controlled Trial
8%
Randomized Trial
34%
Relative Risk
9%
Ribavirin
6%
Risk Factors
6%
Risk of Bias
24%
Risk Ratio
16%
Septic Shock
6%
Serious Adverse Events
22%
Severe Sepsis
5%
Stable Coronary Artery Disease
9%
Statistical Analysis Plan
14%
Stress Ulcer Prophylaxis
7%
Subarachnoid Hemorrhage
14%
Systematic Meta-analysis
55%
Targeted Temperature Management
10%
Testosterone
5%
Treatment as Usual
9%
Trial Protocol
6%
Trigeminal Ganglion
6%
Type 2 Diabetes Mellitus (T2DM)
16%
Type 2 Diabetic Patients
7%
Usual Care
15%
Vasodilator
7%
Medicine and Dentistry
Adolescent
8%
Adverse Event
25%
Alcohol Liver Disease
5%
All Cause Mortality
8%
Apoplexy
7%
Artery
11%
Biological Marker
5%
Brain Injury
5%
Breast Cancer
10%
Calcitonin Gene Related Peptide
7%
Cardiovascular Disease
8%
Cardiovascular System
6%
Clinical Trial
15%
Cohort Analysis
7%
Coronary Artery
5%
Dexamethasone
5%
Diabetes
5%
Disease
19%
Endothelin
5%
Exercise
7%
Hazard Ratio
5%
Heart Arrest
6%
Heart Rehabilitation
6%
Hypothermia
5%
Intensive Care
7%
Intensive Care Unit
14%
Ischemic Heart Disease
5%
Liver Cirrhosis
5%
Lung Cancer
5%
Malignant Neoplasm
15%
Maturity Onset Diabetes of the Young
11%
Meta-Analysis
43%
Migraine
5%
Observational Study
6%
Odds Ratio
5%
Out of Hospital Cardiac Arrest
9%
Outpatient
5%
Patient with Type 2 Diabetes
5%
Physical Activity
7%
Placebo
27%
Prevalence
6%
Prostate Cancer
5%
Quality of Life
21%
Randomized Clinical Trial
63%
Randomized Controlled Trial
21%
Receptor
7%
Rehabilitation Engineering
15%
Sepsis
7%
Septic Shock
6%
Sequential Analysis
41%
Stress Ulcer
5%
Symptom
12%
Systematic Review
53%
Systematic Review with Meta-Analysis
31%